An online survey of tobacco smoking cessation associated with naturalistic psychedelic use

Clinical applications of hallucinogens: A review.

(2016) Albert Garcia-Romeu et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Effects of serotonin 2A/1A receptor stimulation on social exclusion processing

(2016) Katrin H. Preller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neural correlates of the LSD experience revealed by multimodal neuroimaging

(2016) Robin L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

(2015) Rainer Kraehenmann et al.   BIOLOGICAL PSYCHIATRY

Can psychedelic compounds play a part in drug dependence therapy?

(2015) Ben Sessa et al.   BRITISH JOURNAL OF PSYCHIATRY

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

(2015) Frederick S Barrett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

(2015) Michael P Bogenschutz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters

(2015) Lucia Burrai et al.   Legal Medicine

Withdrawal: Expanding a Key Addiction Construct

(2015) Megan E. Piper   NICOTINE & TOBACCO RESEARCH

Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters

(2015) Lucia Burrai et al.   Legal Medicine

The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network

(2015) Fernanda Palhano-Fontes et al.   PLoS One

Pharmacological Treatments for Smoking Cessation

(2014) Kate Cahill et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Homological scaffolds of brain functional networks

(2014) G. Petri et al.   Journal of the Royal Society Interface

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

(2013) Adam R Winstock et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Insula’s functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving

(2013) Matthew T. Sutherland et al.   PSYCHOPHARMACOLOGY

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

(2012) Michael P. Bogenschutz et al.   Drug Testing and Analysis

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Prediction of Psilocybin Response in Healthy Volunteers

(2012) Erich Studerus et al.   PLoS One

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers

(2011) Matthew W. Johnson et al.   DRUG AND ALCOHOL DEPENDENCE

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Determinants of Tobacco Use and Renaming the FTND to the Fagerstrom Test for Cigarette Dependence

(2011) K. Fagerstrom   NICOTINE & TOBACCO RESEARCH

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Mephedrone, new kid for the chop?

(2010) Adam R. Winstock et al.   ADDICTION

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials

(2008) Salvatore Mottillo et al.   EUROPEAN HEART JOURNAL

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY